Literature DB >> 11686071

Mechanical and pharmacologic treatment of vasospasm.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11686071      PMCID： PMC8172378     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  15 in total

1.  Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm.

Authors:  P Vajkoczy; P Horn; C Bauhuf; E Munch; U Hubner; D Ing; C Thome; C Poeckler-Schoeninger; H Roth; P Schmiedek
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

2.  Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH.

Authors:  Y N Zubkov; B M Nikiforov; V A Shustin
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

3.  Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage.

Authors:  D W Newell; J M Eskridge; M R Mayberg; M S Grady; H R Winn
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

4.  Transluminal angioplasty for treatment of intracranial arterial vasospasm.

Authors:  R T Higashida; V V Halbach; L D Cahan; M Brant-Zawadzki; S Barnwell; C Dowd; G B Hieshima
Journal:  J Neurosurg       Date:  1989-11       Impact factor: 5.115

5.  Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration.

Authors:  J M Milburn; C J Moran; D T Cross; M N Diringer; T K Pilgram; R G Dacey
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

6.  Intraarterial papaverine for the treatment of vasospasm.

Authors:  M P Marks; G K Steinberg; B Lane
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jul-Aug       Impact factor: 3.825

7.  Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage.

Authors:  T J Coyne; W J Montanera; R L Macdonald; M C Wallace
Journal:  Can J Surg       Date:  1994-10       Impact factor: 2.089

8.  Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm.

Authors:  J D Barr; J M Mathis; J A Horton
Journal:  AJNR Am J Neuroradiol       Date:  1994-04       Impact factor: 3.825

9.  Papaverine-induced mydriasis.

Authors:  L E Hendrix; J E Dion; M E Jensen; C D Phillips; S A Newman
Journal:  AJNR Am J Neuroradiol       Date:  1994-04       Impact factor: 3.825

10.  Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage.

Authors:  J E Clouston; Y Numaguchi; G H Zoarski; E F Aldrich; J M Simard; K M Zitnay
Journal:  AJNR Am J Neuroradiol       Date:  1995-01       Impact factor: 3.825
View more
  4 in total

Review 1.  Clinical Presentation, Imaging, and Management of Complications due to Neurointerventional Procedures.

Authors:  Matthew C Davis; John P Deveikis; Mark R Harrigan
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Impact of percutaneous transluminal angioplasty for treatment of cerebral vasospasm on subarachnoid hemorrhage patient outcomes.

Authors:  Rakesh Khatri; Muhammad Zeeshan Memon; Haralabos Zacharatos; Ather M Taqui; Mushtaq H Qureshi; Gabriela Vazquez; M Fareed K Suri; Gustavo J Rodriguez; Ramachandra P Tummala; Mustapha A Ezzeddine; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm.

Authors:  Neeraj Badjatia; Mehmet A Topcuoglu; Johnny C Pryor; James D Rabinov; Christopher S Ogilvy; Bob S Carter; Guy A Rordorf
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

4.  Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.

Authors:  Qaisar A Shah; Muhammad Zeeshan Memon; M Fareed K Suri; Gustavo J Rodriguez; Osman S Kozak; Robert A Taylor; Ramachandra P Tummala; Gabriela Vazquez; Alexandros L Georgiadis; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2009-04-16       Impact factor: 3.210
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.